87 related articles for article (PubMed ID: 8392499)
21. Regulation of hypothalamic proopiomelanocortin by leptin in lean and obese rats.
Korner J; Chua SC; Williams JA; Leibel RL; Wardlaw SL
Neuroendocrinology; 1999 Dec; 70(6):377-83. PubMed ID: 10657730
[TBL] [Abstract][Full Text] [Related]
22. Moderate Exercise Prevents Functional Remodeling of the Anterior Pituitary Gland in Diet-Induced Insulin Resistance in Rats: Role of Oxidative Stress and Autophagy.
Mercau ME; Repetto EM; Perez MN; Martinez Calejman C; Sanchez Puch S; Finkielstein CV; Cymeryng CB
Endocrinology; 2016 Mar; 157(3):1135-45. PubMed ID: 26672805
[TBL] [Abstract][Full Text] [Related]
23. Proopiomelanocortin-derived peptides in rat cerebrospinal fluid and hypothalamic extracts: evidence that secretion is regulated with respect to energy balance.
Pritchard LE; Oliver RL; McLoughlin JD; Birtles S; Lawrence CB; Turnbull AV; White A
Endocrinology; 2003 Mar; 144(3):760-6. PubMed ID: 12586751
[TBL] [Abstract][Full Text] [Related]
24. Age-related changes in proopiomelanocortin messenger ribonucleic acid levels in hypothalamus and pituitary of female C57BL/6J mice.
Nelson JF; Bender M; Schachter BS
Endocrinology; 1988 Jul; 123(1):340-4. PubMed ID: 2454803
[TBL] [Abstract][Full Text] [Related]
25. Immunoreactive corticotropin-releasing hormone levels in the hypothalamus of female Wistar fatty rats.
Fukushima M; Nakai Y; Tsukada T; Naito Y; Nakaishi S; Tominaga T; Murakami N; Kawamura H; Fukata J; Ikeda H
Neurosci Lett; 1992 Apr; 138(2):245-8. PubMed ID: 1608536
[TBL] [Abstract][Full Text] [Related]
26. Changes in rat pituitary POMC mRNA after exposure to cold or a novel environment, detected by in situ hybridization.
Wu P; Childs GV
J Histochem Cytochem; 1991 Jun; 39(6):843-52. PubMed ID: 1851778
[TBL] [Abstract][Full Text] [Related]
27. Pro-opiomelanocortin mRNA and peptide co-expression in the developing rat pituitary.
Khachaturian H; Kwak SP; Schafer MK; Watson SJ
Brain Res Bull; 1991 Feb; 26(2):195-201. PubMed ID: 1849441
[TBL] [Abstract][Full Text] [Related]
28. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.
Stefaneanu L; Kovacs K; Horvath E; Lloyd RV
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):107-13. PubMed ID: 1651583
[TBL] [Abstract][Full Text] [Related]
29. In situ hybridization study of obesity-associated alteration in growth hormone mRNA levels.
Ahmad I; Steggles AW; Finkelstein JA
Int J Obes Relat Metab Disord; 1992 Jun; 16(6):435-41. PubMed ID: 1322869
[TBL] [Abstract][Full Text] [Related]
30. Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries.
de Keyzer Y; Bertagna X; Lenne F; Girard F; Luton JP; Kahn A
J Clin Invest; 1985 Nov; 76(5):1892-8. PubMed ID: 2997296
[TBL] [Abstract][Full Text] [Related]
31. Study of pro-opiomelanocortin mRNA expression in human postmortem pituitaries.
Mengod G; Vivanco MM; Christnacher A; Probst A; Palacios JM
Brain Res Mol Brain Res; 1991 May; 10(2):129-37. PubMed ID: 1712887
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of pro-opiomelanocortin gene expression by glucocorticoids in the denervated rat intermediate pituitary gland.
Seger MA; van Eekelen JA; Kiss JZ; Burbach JP; de Kloet ER
Neuroendocrinology; 1988 Apr; 47(4):350-7. PubMed ID: 3374760
[TBL] [Abstract][Full Text] [Related]
33. Regulation of opioid gene expression.
Civelli O; Birnberg N; Comb M; Douglass J; Lissitzky JC; Uhler M; Herbert E
Peptides; 1983; 4(5):651-6. PubMed ID: 6318201
[TBL] [Abstract][Full Text] [Related]
34. Pro-opiomelanocortin mRNA levels fall in the fetal sheep pituitary before birth.
McMillen IC; Mercer JE; Thorburn GD
J Mol Endocrinol; 1988 Sep; 1(2):141-5. PubMed ID: 3255361
[TBL] [Abstract][Full Text] [Related]
35. Development of pituitary pro-opiomelanocortin gene and peptide expression: characterization and effect of repeated intermittent maternal isolation.
Vázquez DM; Akil H
Neuroendocrinology; 1992 Sep; 56(3):320-30. PubMed ID: 1436371
[TBL] [Abstract][Full Text] [Related]
36. Analysis of endocrine active and clinically silent corticotropic adenomas by in situ hybridization.
Lloyd RV; Fields K; Jin L; Horvath E; Kovacs K
Am J Pathol; 1990 Aug; 137(2):479-88. PubMed ID: 2167013
[TBL] [Abstract][Full Text] [Related]
37. Differential alterations by chronic treatment with morphine of pro-opiomelanocortin mRNA levels in anterior as compared to intermediate pituitary lobes of rats.
Höllt V; Haarmann I
Neuropeptides; 1985 Feb; 5(4-6):481-4. PubMed ID: 4000418
[TBL] [Abstract][Full Text] [Related]
38. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes.
Lyons PD; Blalock JE
J Neuroimmunol; 1997 Sep; 78(1-2):47-56. PubMed ID: 9307227
[TBL] [Abstract][Full Text] [Related]
39. Regulation of pro-opiomelanocortin gene transcription in individual cell nuclei.
Fremeau RT; Lundblad JR; Pritchett DB; Wilcox JN; Roberts JL
Science; 1986 Dec; 234(4781):1265-9. PubMed ID: 3775385
[TBL] [Abstract][Full Text] [Related]
40. Response of pituitary and spleen pro-opiomelanocortin mRNA, and spleen and thymus interleukin-1 beta mRNA to adjuvant arthritis in the rat.
Stephanou A; Sarlis NJ; Knight RA; Chowdrey HS; Lightman SL
J Neuroimmunol; 1992 Mar; 37(1-2):59-63. PubMed ID: 1548377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
